Quick Links: Skip to main page content Skip to Search Skip to Topics Menu Skip to Section Content Menu Skip to Common Links
-

Vaccines, Blood & Biologics

  • Share Share this page

Section Contents Menu

-

Resources for You

-
-

Cervarix

Proper Name: Human Papillomavirus Bivalent (Types 16 and 18) Vaccine, Recombinant
Tradename: Cervarix
Manufacturer: GlaxoSmithKline Biologicals
Indications: 

  • prevention of cervical cancer, cervical intraepithelial neoplasia (CIN) grade 2 or worse and adenocarcinoma in situ, and cervical intraepithelial neoplasia (CIN) grade 1, caused by oncogenic human papillomavirus (HPV) types 16 and 18, in females 10 through 25 years of age
    
-

Product Information

-
-

Supporting Documents

-
 

Contact Us

  • Consumer Affairs Branch (CBER)

  • (800) 835-4709
  • (301) 827-1800

    • Division of Communication and Consumer Affairs

    Office of Communication, Outreach and Development

    Food and Drug Administration

    1401 Rockville Pike

    Suite 200N/HFM-47

    Rockville, MD 20852-1448

-
-
-
-
-
-